| MiRNA | Compound | Condition | Effect | Throughput | PMID | Details |
|---|---|---|---|---|---|---|
| let-7a | Gemcitabine | pancreatic cancer | Sensitive | High | 19654291 | |
| let-7b | Gemcitabine | pancreatic cancer | Sensitive | High | 19654291 | |
| let-7c | Gemcitabine | pancreatic cancer | Sensitive | High | 19654291 | |
| let-7d | Gemcitabine | pancreatic cancer | Sensitive | High | 19654291 | |
| let-7f | Gemcitabine | pancreatic cancer | Sensitive | High | 19654291 | |
| let-7a | Gemcitabine | pancreatic cancer | Resistant | Low | 23335963 | |
| let-7i | Gemcitabine | Bladder Carcinoma | Resistant | High | 23946872 | |
| let-7a* | Gemcitabine | cholangiocarcinoma | Resistant | High | 24147037 | |
| let-7f-2* | Gemcitabine | cholangiocarcinoma | Resistant | High | 24147037 | |
| let-7d | Gemcitabine | pancreatic cancer | Resistant | High | 25117811 | |
| let-7f-1* | Gemcitabine | pancreatic cancer | Resistant | High | 25117811 | |
| let-7i | Gemcitabine | pancreatic cancer | Resistant | High | 25117811 | |
| let-7 | Gemcitabine | KRAS mutation cancer | Sensitive | Low | 25946136 |